PolyPeptide Group AG (SWX:PPGN)
Switzerland
· Delayed Price · Currency is CHF 20.10
-0.05 (-0.25%)
May 13, 2025, 3:45 PM CET
PolyPeptide Group AG Market Cap
PolyPeptide Group AG has a market cap or net worth of 664.88 million as of May 13, 2025. Its market cap has decreased by -32.10% in one year.
Market Cap
664.88M
Enterprise Value
699.23M
Revenue
315.97M
Ranking
n/a
PE Ratio
n/a
Stock Price
20.10
Market Cap Chart
Since April 29, 2021, PolyPeptide Group AG's market cap has decreased from 2.59B to 664.88M, a decrease of -74.33%. That is a compound annual growth rate of -28.59%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 12, 2025 | 664.88M | -29.02% |
| Dec 30, 2024 | 936.73M | 62.30% |
| Dec 29, 2023 | 577.18M | -30.79% |
| Dec 30, 2022 | 833.98M | -81.57% |
| Dec 30, 2021 | 4.53B | 74.70% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Roche Holding AG | 209.97B |
| Novartis AG | 178.12B |
| Lonza Group AG | 40.67B |
| Alcon | 39.60B |
| Galderma Group AG | 23.81B |
| Straumann Holding AG | 17.82B |
| Sandoz Group AG | 16.28B |
| Sonova Holding AG | 15.87B |